SCHEMBL13614838

SCHEMBL13614838

Bc1ccc(C(=O)CCC(=O)OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.48
▸ MAPT P10636 3/20 0.48
▸ LMNA P02545 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ MMP1 P03956 1/20 0.47
▸ MEN1 O00255 3/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ ESRRB O95718 1/20 0.43
▸ CTNNB1 P35222 1/20 0.42
▸ WNT3A P56704 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ PDE4B Q07343 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2305014 0.83 HSD17B3 (0.60) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL8535748 0.83 KMT2A (0.63) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL640759 0.81 LMNA (0.60) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL7398 0.81 KMT2A (0.64) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL10787656 0.81 KMT2A (0.48) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL10638823 0.81 KMT2A (0.48) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL9263357 0.81 KMT2A (0.60) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL1108994 0.81 MMP1 (0.70) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL135356 0.81 NR4A2 (0.61) KMT2AMAPTLMNAALDH1A1HTT
SCHEMBL3457642 0.80 KMT2A (0.47) KMT2AMAPTLMNAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432700-B1 SPIRO-HYDANTOIN COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS BRISTOL MYERS SQUIBB CO (US) 2009-11-04 — — EP disclosed
Send feedback